Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4687872019 | Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4687873012 | Ipratropium and levosalbutamol only product in pulmonary dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4687874018 | Ipratropium and levalbuterol only product in pulmonary dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | Has manufactured dose form | Pulmonary dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | Has active ingredient | Levosalbutamol | true | Inferred relationship | Some | 1 | |
| Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | Has active ingredient | Ipratropium (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | Is a | Ipratropium and levosalbutamol only product | true | Inferred relationship | Some | ||
| Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | Is a | Product containing ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurised solution for inhalation | Is a | True | Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Is a | True | Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR